Searched for
BAYER CLINICAL TRIALS
Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claimsA US judge has dismissed Bayer's plea to halt Johnson & Johnson's advertising for its prostate cancer drug Erleada. Bayer alleged false cla...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- Pricing depends on the country, Bayer looks at affordability: ExecutiveIndia has evolved significantly in the clinical trial setting...we have a significant number of patients and trials running in IndiaAshraf ...
- Bayer steps up India R&D, clinical trials"Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a...
- Natco gets emergency use nod for Baricitinib to treat Covid without trialsIn a statement, the Hyderabad headquartered pharma company said Baricitinib in combination with Remdesivir is used for the treatment of Cov...
- Pan-European consortium seeks big pharma partner for COVID-19 shotA pan-European consortium developing a COVID-19 vaccine is in talks with big pharma to support the late-stage development of its shot and r...
- Bayer aims to help CureVac with COVID-19 vaccine output, says CEOThough inoculation campaigns have started around the world using various COVID-19 vaccines, many countries say their ability to get shots i...
- Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billionGermany’s Bayer will pay $2 billion upfront and up to an additional $2 billion in milestone payments contingent on development achievements...
- Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitungOther companies including Bayer and Teva have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing i...
- Indian drug makers can export patented meds for approval: Delhi High CourtNatco and Alembic, however, were directed to undertake that during the life of the respective patent, they will not export the respective p...
- Delhi High Court favours Natco, Alembic; allows them to export generics of Bayer's drugsBayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand '...
- Infosys launches solution to tap clinical trial marketThe new cloud-based module of the CTSM solution is an enhancement to the existing on-premise version that offers tools to manage all aspect...
- After SC rap, govt set to notify rules to regulate drug trialsAsking for the personal presence of Health Secretary in the matter, the SC gave the Ministry four weeks to respond to a PIL.
- Pharmaceutical companies such as Cipla, Sun Pharma deny wrongdoing in introducing new drugsCipla said as per the law, it is not mandatory to carry out Phase III trials in India for each and every new drug.
- Pharmaceutical companies including Cipla deny charges of collusion with drug regulator in drug trialsSeveral drug manufacturers accused of colluding with the sector regulator and medical experts to allegedly violate approval norms have deni...
- Piramal acquires Bayer's molecular imaging portfolio"We had said earlier we will change the idea of our pharma business.We will be moving away from branded generics to intellectual property,"...
- Piramal acquires molecular imaging R&D portfolio of BayerPiramal Healthcare today announced its second major acquisition with worldwide rights to the molecular imaging research and development por...
- Two new TB drugs enter advanced stages of clinical trialTwo new drugs against tuberculosis have reached the advanced stages of clinical trial and could be made available for use by 2012-2014.
Load More
